60 DEGREES PHARMACEUTICALS, INC. — All Filings
195 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
4
424B4
424B5
8-A12B
8-A12B/A
8-K
CERT
CORRESP
D
DEF 14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| UPLOAD | — | 0000000000-25-001942 | Feb 19, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-001269 | Feb 14, 2025 | — |
| S-1 | REGISTRATION STATEMENT | 0001213900-25-014334 | Feb 14, 2025 | — |
| D | — | 0001946563-25-000002 | Feb 12, 2025 | — |
| D | — | 0001946563-25-000001 | Feb 11, 2025 | — |
| SCHEDULE 13G | — | 0001213900-25-012260 | Feb 11, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-010962 | Feb 6, 2025 | Feb 5, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-010772 | Feb 6, 2025 | — |
| SCHEDULE 13G | — | 0001213900-25-009426 | Feb 3, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-008463 | Jan 30, 2025 | Jan 28, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-008098 | Jan 30, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-007529 | Jan 28, 2025 | — |
| 4 | — | 0001213900-25-006572 | Jan 24, 2025 | Jan 2, 2025 |
| 4 | — | 0001213900-25-006569 | Jan 24, 2025 | Jan 2, 2025 |
| 4 | — | 0001213900-25-005055 | Jan 21, 2025 | Jan 17, 2025 |
| 4 | — | 0001213900-25-005051 | Jan 21, 2025 | Jan 17, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-002070 | Jan 8, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001213900-24-110269 | Dec 18, 2024 | Dec 12, 2024 |
| 4 | — | 0001213900-24-107011 | Dec 9, 2024 | Dec 5, 2024 |
| 4 | — | 0001213900-24-101110 | Nov 21, 2024 | Nov 19, 2024 |
| SC 13G | — | 0001172661-24-005107 | Nov 14, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-098195 | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-24-097440 | Nov 13, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-095068 | Nov 6, 2024 | — |
| DEF 14A | PROXY STATEMENT | 0001213900-24-087749 | Oct 15, 2024 | Nov 6, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-086079 | Oct 8, 2024 | Oct 2, 2024 |
| PRE 14A | PROXY STATEMENT | 0001213900-24-084401 | Oct 2, 2024 | — |
| EFFECT | — | 9999999995-24-003042 | Sep 30, 2024 | — |
| CORRESP | — | 0001213900-24-082339 | Sep 26, 2024 | — |
| UPLOAD | — | 0000000000-24-010843 | Sep 24, 2024 | — |
| S-3 | REGISTRATION STATEMENT | 0001213900-24-080313 | Sep 19, 2024 | — |
| 4 | — | 0001213900-24-077746 | Sep 11, 2024 | Aug 27, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-076515 | Sep 6, 2024 | Sep 4, 2024 |
| 8-K | FORM 8-K | 0001213900-24-073351 | Aug 28, 2024 | Aug 26, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-068942 | Aug 14, 2024 | Aug 12, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-068673 | Aug 14, 2024 | Jun 30, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-067535 | Aug 12, 2024 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-24-064753 | Aug 2, 2024 | — |
| 8-K | FORM 8-K | 0001013762-24-001604 | Jul 26, 2024 | Jul 25, 2024 |
| 424B5 | 424B5 | 0001013762-24-001424 | Jul 26, 2024 | — |
| 424B5 | 424B5 | 0001013762-24-000773 | Jul 24, 2024 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-24-063291 | Jul 22, 2024 | — |
| EFFECT | — | 9999999995-24-002202 | Jul 18, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-061853 | Jul 16, 2024 | — |
| CORRESP | — | 0001213900-24-061556 | Jul 16, 2024 | — |
| UPLOAD | — | 0000000000-24-008020 | Jul 15, 2024 | — |
| S-3 | REGISTRATION STATEMENT | 0001213900-24-061077 | Jul 12, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-060093 | Jul 9, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-056728 | Jun 27, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-052167 | Jun 12, 2024 | Jun 11, 2024 |